investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Systematic identification of oncogenic KRAS synthetic lethal interactions

William C Hahn

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

William C Hahn

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Ronglai Shen

Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis

All cancers but non-melanoma skin cancer Melanoma of skin

Erika L Pearce

Tumor-Imposed Glucose Restrictions on T Cells Dampen Immunity

All cancers but non-melanoma skin cancer

Peter S. Choi

Defining the role of RBM10 in RNA processing and tumor suppression

All cancers but non-melanoma skin cancer Melanoma of skin

Lopa Mishra

Role of Beta Spectrin and Smad in Alcohol Induced Liver and GI Cell Proliferation

All cancers but non-melanoma skin cancer Melanoma of skin

Paul R Jensen

Exploiting Microbial Diversity for Natural Product Discovery

All cancers but non-melanoma skin cancer

Carol Thiele

Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma

All cancers but non-melanoma skin cancer

Peter Blumberg

Molecular Mechanism of Action of Phorbol Ester – Rockville

All cancers but non-melanoma skin cancer

Xinhua Ji

Biomolecular Structure and Mechanism, Structure-Based Drug Design

All cancers but non-melanoma skin cancer

Paul Roche

Mechanisms of MHC Class II Association with Plasma Membrane Microdomains

All cancers but non-melanoma skin cancer